Updated on 03/04/2021

On February 27, 2021, the U.S. Food and Drug Administration issued an Emergency Use Authorization (EUA) for the Janssen Biotech Inc.’s COVID‑19 Vaccine for the prevention of COVID-19 for individuals 18 years of age and older. Review Janssen’s Fact Sheet for Healthcare Providers Administering Vaccine (Vaccination Providers) regarding the limitations of authorized use.

During the COVID-19 Public Health Emergency (PHE), Medicare will cover and pay for the administration of the vaccine (when furnished consistent with the EUA). Review our payment and HCPCS Level I CPT code structure for specific COVID-19 vaccine information. Only bill for the vaccine administration codes when you submit claims to Medicare; don’t include the vaccine product codes when the vaccines are free.

 

 

Related links:

 

Article published by CMS on March 4, 2021
CLICK HERE to read original post